Gary Goldenberg

2.6k total citations
111 papers, 1.8k citations indexed

About

Gary Goldenberg is a scholar working on Dermatology, Epidemiology and Oncology. According to data from OpenAlex, Gary Goldenberg has authored 111 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Dermatology, 47 papers in Epidemiology and 31 papers in Oncology. Recurrent topics in Gary Goldenberg's work include Nonmelanoma Skin Cancer Studies (30 papers), Cutaneous Melanoma Detection and Management (22 papers) and Cutaneous lymphoproliferative disorders research (17 papers). Gary Goldenberg is often cited by papers focused on Nonmelanoma Skin Cancer Studies (30 papers), Cutaneous Melanoma Detection and Management (22 papers) and Cutaneous lymphoproliferative disorders research (17 papers). Gary Goldenberg collaborates with scholars based in United States, Australia and Russia. Gary Goldenberg's co-authors include Rita V. Patel, Valerie R. Yanofsky, Meghan Dubina, Joanna Dong, Yasaman Mansouri, Joseph L. Jorizzo, Peter W. Hashim, Amylynne Frankel, Omar P. Sangüeza and Aaron S. Farberg and has published in prestigious journals such as Scientific Reports, Journal of the American Academy of Dermatology and Neuroreport.

In The Last Decade

Gary Goldenberg

105 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gary Goldenberg United States 25 955 809 341 226 225 111 1.8k
Jee Ho Choi South Korea 24 1.1k 1.1× 418 0.5× 419 1.2× 281 1.2× 232 1.0× 178 2.0k
Hyun‐Chang Ko South Korea 24 894 0.9× 462 0.6× 185 0.5× 342 1.5× 219 1.0× 181 1.7k
Pascale Quatresooz Belgium 19 589 0.6× 465 0.6× 449 1.3× 260 1.2× 181 0.8× 189 1.9k
Mirna Šitum Croatia 24 821 0.9× 385 0.5× 403 1.2× 246 1.1× 284 1.3× 183 2.2k
Georgi Tchernev Bulgaria 25 566 0.6× 582 0.7× 418 1.2× 163 0.7× 310 1.4× 339 2.2k
Mark S. Nestor United States 24 913 1.0× 439 0.5× 154 0.5× 134 0.6× 248 1.1× 105 2.1k
Delphine Kérob France 26 894 0.9× 510 0.6× 627 1.8× 202 0.9× 164 0.7× 137 2.1k
Maria Rita Nasca Italy 27 774 0.8× 666 0.8× 386 1.1× 187 0.8× 503 2.2× 102 2.0k
Shari R. Lipner United States 26 872 0.9× 1.5k 1.9× 222 0.7× 193 0.9× 180 0.8× 344 2.9k
Diane Roseeuw Belgium 29 1.3k 1.3× 825 1.0× 214 0.6× 107 0.5× 183 0.8× 101 2.8k

Countries citing papers authored by Gary Goldenberg

Since Specialization
Citations

This map shows the geographic impact of Gary Goldenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Goldenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Goldenberg more than expected).

Fields of papers citing papers by Gary Goldenberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary Goldenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Goldenberg. The network helps show where Gary Goldenberg may publish in the future.

Co-authorship network of co-authors of Gary Goldenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Gary Goldenberg. A scholar is included among the top collaborators of Gary Goldenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary Goldenberg. Gary Goldenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Berman, Brian, Seemal R. Desai, Aaron S. Farberg, et al.. (2024). Advances in Technology for Melanoma Diagnosis and Prognosis: An Expert Consensus Panel. Journal of Drugs in Dermatology. 23(9). 774–781. 1 indexed citations
3.
Brownstone, Nicholas, Brian Berman, Roger I. Ceilley, et al.. (2023). Incorporating Prognostic Gene Expression Profile Assays into the Management of Cutaneous Melanoma: An Expert Consensus Panel. SKIN The Journal of Cutaneous Medicine. 7(1). 556–569. 5 indexed citations
4.
Khanna, Raveena, et al.. (2018). Diet and dermatology: Google search results for acne, psoriasis, and eczema.. PubMed. 102(1). 44;46;48–44;46;48. 13 indexed citations
5.
Dong, Joanna & Gary Goldenberg. (2017). New biologics in psoriasis: an update on IL-23 and IL-17 inhibitors.. PubMed. 99(2). 123–127. 43 indexed citations
6.
Goldenberg, Gary, et al.. (2017). Biosimilars in psoriasis: the future or not?. PubMed. 99(2). 116–120. 5 indexed citations
7.
Chen, Chen, et al.. (2016). Actinic keratosis as a marker of field cancerization in excision specimens of cutaneous malignancies.. PubMed. 97(6). 415–20. 15 indexed citations
8.
Goldenberg, Gary & Omid Hamid. (2013). Nonsurgical treatment options for basal cell carcinoma - focus on advanced disease.. PubMed. 12(12). 1369–78. 10 indexed citations
9.
Goldenberg, Gary & Omid Hamid. (2013). Understanding BCC pathogenesis: treatment advancements and challenges.. PubMed. 12(10). 1110–20. 4 indexed citations
10.
Hamid, Omid & Gary Goldenberg. (2013). Identifying patients at risk for recurrent or advanced BCC.. PubMed. 12(11). 1246–52; quiz 1253. 10 indexed citations
11.
Goldenberg, Gary, et al.. (2010). American Academy of Dermatology - 2010 summer meeting.. PubMed. 13(10). 683–5. 1 indexed citations
12.
Dana, Ali, et al.. (2009). Verruciform xanthoma in the setting of cutaneous trauma and chronic inflammation: report of a patient and a brief review of the literature. Journal of Cutaneous Pathology. 37(8). 895–900. 24 indexed citations
13.
Abuav, Rachel, et al.. (2009). Development of lichen sclerosus et atrophicus while receiving a therapeutic dose of imatinib mesylate for chronic myelogenous leukemia. Journal of Cutaneous Pathology. 37(8). 877–880. 8 indexed citations
14.
Smith, Edward S., et al.. (2009). Dermatomyositis: A Clinicopathological Study of 40 Patients. American Journal of Dermatopathology. 31(1). 61–67. 43 indexed citations
15.
Goldenberg, Gary, et al.. (2009). Linezolid‐induced purpuric medication reaction. Journal of Cutaneous Pathology. 36(7). 793–795. 6 indexed citations
16.
McCarter, Martin D., et al.. (2008). Hyalinized collagen in a dermatofibrosarcoma protuberans after treatment with imatinib mesylate. Journal of Cutaneous Pathology. 35(11). 1003–1006. 35 indexed citations
17.
Goldenberg, Gary, et al.. (2008). Who sends what: a comparison of dermatopathology referrals from dermatologists, pathologists and dermatopathologists. Journal of Cutaneous Pathology. 35(7). 658–661. 13 indexed citations
18.
Goldenberg, Gary, et al.. (2007). Eruptive squamous cell carcinomas, keratoacanthoma type, arising in a multicolor tattoo. Journal of Cutaneous Pathology. 35(1). 62–64. 39 indexed citations
19.
Goldenberg, Gary, et al.. (2006). US dermatopathology fellows career survey: 2004–2005. Journal of Cutaneous Pathology. 34(6). 487–489. 7 indexed citations
20.
Woodruff‐Pak, Diana S., et al.. (2000). Cerebellar volume in humans related to magnitude of classical conditioning. Neuroreport. 11(3). 609–615. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026